Shares of Pharming Group (OTCMKTS:PHGUF – Get Free Report) reached a new 52-week low on Thursday . The stock traded as low as $0.81 and last traded at $0.81, with a volume of 900 shares trading hands. The stock had previously closed at $0.93.
Pharming Group Stock Performance
The company has a quick ratio of 1.16, a current ratio of 1.43 and a debt-to-equity ratio of 0.14. The company has a 50-day simple moving average of $0.94 and a two-hundred day simple moving average of $1.09.
Pharming Group (OTCMKTS:PHGUF – Get Free Report) last released its quarterly earnings results on Wednesday, May 8th. The biotechnology company reported ($0.02) EPS for the quarter. The company had revenue of $55.59 million for the quarter. Pharming Group had a negative return on equity of 4.54% and a negative net margin of 4.00%.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
Featured Stories
- Five stocks we like better than Pharming Group
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Comparing and Trading High PE Ratio Stocks
- MarketBeat Week in Review – 6/24 – 6/28
- How to Calculate Options Profits
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
